Provided are a monoamine compound and an organic electroluminescence device including the same. The monoamine compound according to an example embodiment is represented by the following Formula 1 ##STR00001##

Provided are a monoamine compound and an organic electroluminescence device including the same. The monoamine compound according to an example embodiment is represented by the following Formula 1 ##STR00001##

Providing a compound that can realize an organic material with an enhanced function.

Provided is a compound represented by the following general formula (1).

##STR00001##

(In the general formula (1), R.sup.101 to R.sup.104 are each independently a univalent substituent group represented by the following general formula (2-1), i to 1 are each independently an integer of 0 or 1, provided that i to 1 are not simultaneously 0.)

##STR00002##

(In the general formula (2-1), R.sup.203 and R.sup.204 are each independently a single bond or a straight chain or branched substituted or unsubstituted alkylene group represented by C.sub.nH.sub.2n (n is an integer of equal to or greater than 1), R.sup.205 is hydrogen or a straight chain or branched substituted or unsubstituted alkyl group represented by C.sub.nH.sub.2n+1 (n is an integer of equal to or greater than 1). Represented by k is an integer of equal to or greater than 1, and X is a bivalent or more-valent aromatic group. If carbon not bonded to R.sup.203 and R.sup.204 is present in the bivalent or more-valent aromatic group, the carbon is unsubstituted or has at least one substituent group. In addition, a part for bonding to R.sup.203 and at least one part for bonding to R.sup.204, possessed by the bivalent or more-valent aromatic group, may be any bondable carbon in the aromatic group. Represented by * in R.sup.101 to R.sup.102 is a part for bonding with carbon that is bondable in a benzene ring condensed with a thiophene ring in the general formula (1). Represented by * in R.sup.103 to R.sup.104 is a part for bonding with carbon that is bondable in the benzene ring not condensed with the thiophene ring in the general formula (1).)

Providing a compound that can realize an organic material with an enhanced function.

Provided is a compound represented by the following general formula (1).

##STR00001##

(In the general formula (1), R.sup.101 to R.sup.104 are each independently a univalent substituent group represented by the following general formula (2-1), i to 1 are each independently an integer of 0 or 1, provided that i to 1 are not simultaneously 0.)

##STR00002##

(In the general formula (2-1), R.sup.203 and R.sup.204 are each independently a single bond or a straight chain or branched substituted or unsubstituted alkylene group represented by C.sub.nH.sub.2n (n is an integer of equal to or greater than 1), R.sup.205 is hydrogen or a straight chain or branched substituted or unsubstituted alkyl group represented by C.sub.nH.sub.2n+1 (n is an integer of equal to or greater than 1). Represented by k is an integer of equal to or greater than 1, and X is a bivalent or more-valent aromatic group. If carbon not bonded to R.sup.203 and R.sup.204 is present in the bivalent or more-valent aromatic group, the carbon is unsubstituted or has at least one substituent group. In addition, a part for bonding to R.sup.203 and at least one part for bonding to R.sup.204, possessed by the bivalent or more-valent aromatic group, may be any bondable carbon in the aromatic group. Represented by * in R.sup.101 to R.sup.102 is a part for bonding with carbon that is bondable in a benzene ring condensed with a thiophene ring in the general formula (1). Represented by * in R.sup.103 to R.sup.104 is a part for bonding with carbon that is bondable in the benzene ring not condensed with the thiophene ring in the general formula (1).)

In one aspect, the present disclosure provides a compound of the formula: (I) wherein the variables are as defined herein. In another aspect, the present disclosure also provides pharmaceutical compositions and methods of use of the compounds disclosed herein.

##STR00001##

The present invention relates to an organic electronic device comprising, between an anode and a cathode, at least one layer selected from an electron injection layer, an electron transport layer or an electron generation layer, the layer comprising at least one compound of the following Formula (I), wherein the compound of Formula (I) comprises one or more moieties -(A).sub.a-L and the remaining positions marked with * are hydrogen or substituents independently selected from the group consisting of deuterium, fluorine, RF, C.sub.1-C.sub.20 linear alkyl, C.sub.3-C.sub.20 branched alkyl, C.sub.1-C.sub.12 linear fluorinated alkyl, CN, RCN, C.sub.6-C.sub.20 aryl, C.sub.2-C.sub.20 heteroaryl, (PO)R.sub.2; wherein each R is independently selected from C.sub.1-C.sub.20 linear alkyl, C.sub.1-C.sub.20 alkoxy, C.sub.1-C.sub.20 thioalkyl, C.sub.3-C.sub.20 branched alkyl, C.sub.3-C.sub.20 cyclic alkyl, C.sub.3-C.sub.20 branched alkoxy, C.sub.3-C.sub.20 cyclic alkoxy, C.sub.3-C.sub.20 branched thioalkyl, C.sub.3-C.sub.20 cyclic thioalkyl, C.sub.6-C.sub.20 aryl and C.sub.2-C.sub.20 heteroaryl; A is selected from substituted or unsubstituted C.sub.6-C.sub.24 aryl or C.sub.2-C.sub.20 heteroaryl; wherein in case that A is substituted, the respective substituents are independently selected from the group consisting of deuterium, fluorine, C.sub.1-C.sub.20 linear alkyl, C.sub.3-C.sub.20 branched alkyl, linear fluorinated C.sub.1-C.sub.12 alkyl, CN, C.sub.6-C.sub.20 aryl, and C.sub.2-C.sub.2 heteroaryl; L is selected from substituted or unsubstituted C.sub.2-C.sub.42 heteroaryl, substituted or unsubstituted C.sub.6-C.sub.24 aryl or a polar group selected from (formula (aa)), (formula (bb)) and (formula (cc)), wherein substituents, if present in the respective group L are independently selected from the group consisting of deuterium, N fluorine, C.sub.1-C.sub.20 linear alkyl, C.sub.3-C.sub.20 branched alkyl, C.sub.3-C.sub.20 cyclic alkyl, C.sub.1-C.sub.20 linear alkoxy, C.sub.3-C.sub.20 branched alkoxy, C.sub.1-C.sub.12 linear fluorinated alkyl, C.sub.1-C.sub.12 linear fluorinated alkoxy, C.sub.3-C.sub.12 branched fluorinated cyclic alkyl, C.sub.3-C.sub.12 fluorinated cyclic alkyl, C.sub.3-C.sub.12 fluorinated cycle alkoxy, CN, RCN, C.sub.6-C.sub.20 aryl, C.sub.2-C.sub.20 heteroaryl, OR, SR, (CO)R, (CO)NR.sub.2, SiR.sub.3, (SO)R (SO).sub.2R, (PO)R.sub.2; wherein each R independently selected from C.sub.1-C.sub.20 linear alkyl, C.sub.1-C.sub.20 alkoxy, C.sub.1-C.sub.20 thioalkyl, C.sub.3-C.sub.20 branched alkyl, C.sub.3-C.sub.20 cyclic alkyl, C.sub.3-C.sub.20 branched alkoxy, C.sub.3-C.sub.20 cyclic alkoxy, C.sub.3-C.sub.20 branched thioalkyl, C.sub.3-C.sub.20 cyclic thioalkyl

Disclosed herein are embodiments of polycyclic aromatic compounds and methods of making and using the same. Various different types of polycyclic ring systems are disclosed, including, but not limited to, polymeric aromatic compounds (e.g., nanographene compounds), pentacene-like compounds, chiral aromatic compounds, asymmetric arene compounds formed from naphthalene-, anthracene-, phenanthrene-, and pyrene-based starting compounds, and dimerized aromatic compounds. Also disclosed herein are novel benzannulation-based methods for making the disclosed polycyclic aromatic compounds.

The present invention provides compounds of formulae (1) (2) wherein R.sup.1 and R.sup.2 are C.sub.1-30alkyl, C.sub.2-3O-alkenyl, C.sub.2-30-alkynyl, C.sub.5-7-cycloalkyl, C.sub.6-14-aryl or 5 to 14 membered heteroaryl, wherein C.sub.1-30-alkyl, C.sub.2-3O-alkenyl and C.sub.2-3O-alkynyl can be substituted with one or more substituents selected from the group consisting of halogen, phenyl, OC.sub.1-20-alkyl, OC.sub.2-20-alkenyl and OC.sub.2-2O-alkynyl, and wherein C.sub.5-7-cycloalkyl, C.sub.6-14-aryl and 5 to 14 membered heteroaryl can be substituted with one or more substituents selected from the group consisting of halogen, C.sub.1-20alkyl, C.sub.2-2O-alkenyl, C.sub.2-2O-alkynyl, OC.sub.1-20-alkyl, OC.sub.2-2o-alkenyl and OC.sub.2-2o-alkynyl, R.sup.a, R.sup.b, R.sup.c and R.sup.d are independently and at each occurrence selected from the group consisting of C.sub.1-30alkyl, C.sub.2-30-alkenyl, C.sub.2-30-alkynyl, C.sub.6-14-aryl and 5 to 14 membered heteroaryl, wherein C.sub.1-30-alkyl, C.sub.2-3o-alkenyl and C.sub.2-3o-alkynyl can be substituted with one or more substituents selected from the group consisting of halogen, phenyl, OC.sub.1-20-alkyl, OC.sub.2-20-alkenyl and OC.sub.2-20-alkynyl, and wherein C.sub.5-7-cycloalkyl, C.sub.6-14-aryl and 5 to 14 membered heteroaryl can be substituted with one or more substituents selected from the group consisting of halogen, C.sub.1-20alkyl, C.sub.2-2o-alkenyl, C.sub.2-20-alkynyl, OC.sub.1-20-alkyl, OC.sub.2-20-alkenyl and OC.sub.2-2o-alkynyl, n and o are independently 0, 1, 2, 3, 4 or 5, and m and p are independently 0, 1, 2 or 3, and to electronic device comprising the compounds of formulae 1 or 2.

##STR00001##

The present invention provides compounds of formulae (1) (2) wherein R.sup.1 and R.sup.2 are C.sub.1-30alkyl, C.sub.2-3O-alkenyl, C.sub.2-30-alkynyl, C.sub.5-7-cycloalkyl, C.sub.6-14-aryl or 5 to 14 membered heteroaryl, wherein C.sub.1-30-alkyl, C.sub.2-3O-alkenyl and C.sub.2-3O-alkynyl can be substituted with one or more substituents selected from the group consisting of halogen, phenyl, OC.sub.1-20-alkyl, OC.sub.2-20-alkenyl and OC.sub.2-2O-alkynyl, and wherein C.sub.5-7-cycloalkyl, C.sub.6-14-aryl and 5 to 14 membered heteroaryl can be substituted with one or more substituents selected from the group consisting of halogen, C.sub.1-20alkyl, C.sub.2-2O-alkenyl, C.sub.2-2O-alkynyl, OC.sub.1-20-alkyl, OC.sub.2-2o-alkenyl and OC.sub.2-2o-alkynyl, R.sup.a, R.sup.b, R.sup.c and R.sup.d are independently and at each occurrence selected from the group consisting of C.sub.1-30alkyl, C.sub.2-30-alkenyl, C.sub.2-30-alkynyl, C.sub.6-14-aryl and 5 to 14 membered heteroaryl, wherein C.sub.1-30-alkyl, C.sub.2-3o-alkenyl and C.sub.2-3o-alkynyl can be substituted with one or more substituents selected from the group consisting of halogen, phenyl, OC.sub.1-20-alkyl, OC.sub.2-20-alkenyl and OC.sub.2-20-alkynyl, and wherein C.sub.5-7-cycloalkyl, C.sub.6-14-aryl and 5 to 14 membered heteroaryl can be substituted with one or more substituents selected from the group consisting of halogen, C.sub.1-20alkyl, C.sub.2-2o-alkenyl, C.sub.2-20-alkynyl, OC.sub.1-20-alkyl, OC.sub.2-20-alkenyl and OC.sub.2-2o-alkynyl, n and o are independently 0, 1, 2, 3, 4 or 5, and m and p are independently 0, 1, 2 or 3, and to electronic device comprising the compounds of formulae 1 or 2.

##STR00001##

The present invention provides compounds as PPAR agonists and their application, involving a new class of peroxisome proliferator-activated receptor (PPAR) gamma receptor agonist, which can inhibit the production of mitochondrial reactive oxygen species, and most of which can readily cross the blood-brain barrier. The present invention also includes pharmaceutical uses of the compounds.